Countries like USA, UK, Australia, etc., where precision medicine initiatives are in clinical operation for many therapeutic classes of drugs or the countries having the infrastructure facilities to screen the ABCB1 C3435T genotype testing, it is suggested to start genetic testing of this variant for patients with COVID-19 and provide personalized antiviral therapy accordingly. This evidence concerns the gene ABCB1 and COVID-19.